McDonnell Boehnen Hulbert & Berghoff LLP partner Andrew Williams., Ph.D., authored an article entitled, “How would patent reform legislation in the United States impact the pharmaceutical industry?,” that appears in the November 12, 2014 online edition of the Informa Healthcare’s journal Expert Opinion on Therapeutic Patents. In the article, Dr. Williams discusses why the proposed patent reform legislation will likely disrupt the delicate balance established for Hatch-Waxman-type litigation. View the article
